<DOC>
	<DOCNO>NCT01145339</DOCNO>
	<brief_summary>The study primary objective compare clinical efficacy two formulation supportive treatment lactose intolerance .</brief_summary>
	<brief_title>A Non-inferiority , Multicenter Randomized , Single-Dose Study About Treatment Hypolactasia ( LAILAI )</brief_title>
	<detailed_description />
	<mesh_term>Lactose Intolerance</mesh_term>
	<criteria>1 . The patient male female , age 18 60 year old ; 2 . Have medical history consistent lactose intolerance , confirm test hydrogen expire air ; 3 . The female patient agree use birth control method study participation ; 4 . To able meet study instruction visit require ; 5 . To give free consent participate study sign inform consent form ( ICF ) . 1 . Smoking ; 2 . Secondary hypolactasia ; 3 . Gastrointestinal inflammatories diseases present diverticular disease , diabetic gastropathy neoplasia ; 4 . Colonoscopy colon cleaning procedure 4 week start study 5 . Latrogenic : unnoticed intake laxative overthecounter drug alternative medicine , intake cereal bran probiotic ; 6 . Diagnosis HIV , immunodepression origin , cancer treatment . 7 . Diagnosis comorbidity , investigator 's discretion , may compromise study participation ( e.g. , systemic infection study use antibiotic last 4 week , diabetes mellitus , uncontrolled hypertension renal failure ) , 8 . Hypersensitivity previous laboratory clinical adverse event relate use lactase component formulation use study ; 9 . Incapacity understand complete study questionnaire , include question require use Visual Analogue Scale ICF ; 10 . Pregnancy lactation ; 11 . Use alcohol , exceed 3 dos daily ; 12 . Participation another clinical study last 12 month ; 13 . Patient chronic pulmonary disease , investigator 's opinion , may harm interfere expire hydrogen test ( e.g. , cystic fibrosis ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2011</verification_date>
</DOC>